UBS Remains Sidelined on Edgewell Personal Care Company (EPC) Following 4Q EPS Beat
Get Alerts EPC Hot Sheet
Rating Summary:
3 Buy, 9 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
UBS reiterated a Neutral rating on Edgewell Personal Care Company (NYSE: EPC) price target of $86.00 (from $85.00) following the company's 4Q earnings report. EPC delivered EPS of $1.06, compared to the consensus of $0.96. Management expects adjusted EPS of $3.80-$4.00 in 2017.
Analyst Stephen Powers commented, "Amidst an increasingly challenging HPC landscape, EPC delivered optically solid EPS of $1.06 against UBSe/cons. of $1.02/$0.96 (although we’d note that its tax rate was ~5 points below our estimates of ~27% (or a 7c benefit to EPS) that came alongside strong organic growth of +9.2% (vs. UBSe of +3.1%). Leveraging broad-based sales strength (Wet shave +7.4% organic, Sun and Skin Care +18.2% organic, and Feminine Care +11.4% organic), EPC drove gross margin expansion of +295 bps (vs. UBSe of +155 bps) as it reduced trade spend and benefited from lower material costs. Looking ahead to FY17, EPC expects adjusted EPS of $3.80-$4.00, 100%+ FCF productivity (on GAAP earnings), 50+ bps of operating margin expansion, and +LSD sales growth (including a +40 bps contribution from the Bulldog acquisition)."
For an analyst ratings summary and ratings history on Edgewell Personal Care click here. For more ratings news on Edgewell Personal Care click here.
Shares of Edgewell Personal Care closed at $79.53 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prysmian SpA (PRY:IM) (PRYMY) PT Raised to EUR53 at HSBC
- Piper Sandler Downgrades Southwestern Energy (SWN) to Neutral
- Warren Buffet's Berkshire stock target raised at UBS into earnings
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBS, Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!